Sudarshan Pharma Industries (BOM:543828) Total Liabilities: ₹ Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:543828 Sudarshan Pharma Industries Ltd BOM:543828
85 GF Score
Price ₹39.67
GF Value ₹39.04
Valuation Fairly Valued
! 13 Warning Signs
View Full Analysis

What is Sudarshan Pharma Industries Total Liabilities?

Sudarshan Pharma Industries BOM:543828 -0.58% 85 Total Liabilities is ₹ Mil as of Jun. 2026. GuruFocus rates BOM:543828 with a GF Score™ of 85/100 and a GF Value™ of ₹39.04 (Fairly Valued). The stock has 13 warning signs investors should review.

Sudarshan Pharma Industries's Total Liabilities for the quarter that ended in Jun. 2026 was ₹ Mil.

Sudarshan Pharma Industries's quarterly Total Liabilities increased from Dec. 2025 (₹ Mil) to Mar. 2026 (₹4,854.32 Mil) but then declined from Mar. 2026 (₹4,854.32 Mil) to Jun. 2026 (₹ Mil).

Sudarshan Pharma Industries's annual Total Liabilities increased from Mar. 2024 (₹1,714.72 Mil) to Mar. 2025 (₹2,711.09 Mil) and increased from Mar. 2025 (₹2,711.09 Mil) to Mar. 2026 (₹4,854.32 Mil).

Sudarshan Pharma Industries Total Liabilities Historical Data

* Premium members only.

The historical data trend for Sudarshan Pharma Industries's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sudarshan Pharma Industries Total Liabilities Chart

Sudarshan Pharma Industries Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Liabilities
Get a 7-Day Free Trial 1,077.47 1,315.35 1,714.72 2,711.09 4,854.32

Sudarshan Pharma Industries Quarterly Data
Jun22 Jun25 Sep25 Dec25 Mar26 Jun26
Total Liabilities Get a 7-Day Free Trial - 3,661.84 - 4,854.32 -
BOM:543828
85GF Score
Sudarshan Pharma Industries Ltd BOM:543828
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sudarshan Pharma Industries Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Sudarshan Pharma Industries's Total Liabilities for the fiscal year that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=4561.192+(286.283+5.3379999999997
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+++1.507)
=4,854

Total Liabilities=Total Assets (A: Mar. 2026 )-Total Equity (A: Mar. 2026 )
=6417.491-1563.171
=4,854

Sudarshan Pharma Industries's Total Liabilities for the quarter that ended in Jun. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=+(+
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+++1.507)
=N/A

Total Liabilities=Total Assets (Q: Jun. 2026 )-Total Equity (Q: Jun. 2026 )
=N/A-N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of ₹ Mil mean?
Sudarshan Pharma Industries (BOM:543828) has a Total Liabilities of ₹ Mil as of Jun. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Sudarshan Pharma Industries and its competitors.
Is Sudarshan Pharma Industries' Total Liabilities too high?
Sudarshan Pharma Industries' current Total Liabilities is ₹ Mil. Overall, Sudarshan Pharma Industries has a GF Score™ of 85/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sudarshan Pharma Industries' Total Liabilities compare to DOW?
Sudarshan Pharma Industries' Total Liabilities of ₹ Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Chemicals company?
A good Total Liabilities depends on the Chemicals industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Sudarshan Pharma Industries and its competitors. Sudarshan Pharma Industries's current Total Liabilities is ₹ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sudarshan Pharma Industries stock overvalued right now?
Based on GuruFocus' analysis, Sudarshan Pharma Industries (BOM:543828) is currently considered Fairly Valued. The stock's GF Value™ is ₹39.04, compared to a current price of ₹39.67 — trading 1.6% above its estimated fair value. The current Total Liabilities is ₹ Mil. Sudarshan Pharma Industries' overall GF Score™ is 85/100 with 13 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Sudarshan Pharma Industries (BOM:543828), the current Total Liabilities is ₹ Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sudarshan Pharma Industries (BOM:543828) Overvalued in 2026?

Based on GuruFocus' analysis, Sudarshan Pharma Industries stock appears to be overvalued. The current stock price of ₹39.67 is trading 1.6% above its estimated GF Value™ of ₹39.04. GuruFocus considers Sudarshan Pharma Industries to be Fairly Valued.

Key valuation signals for BOM:543828:

  • Total Liabilities: ₹ Mil
  • GF Value™: ₹39.04 vs. price of ₹39.67 (1.6% above fair value)
  • GF Score™: 85/100 with 13 warning signs

No single metric tells the full story. See the BOM:543828 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sudarshan Pharma Industries Business Description

Address S V Road, 301, 3rd Floor, Aura Biplex, Above Kalyan Jewellers, Borivali (West), Mumbai, MH, IND, 400092
Sudarshan Pharma Industries Ltd operates in the pharmaceutical and chemical industries, focusing on specialty chemicals and intermediates used in pharmaceuticals, paints, food products, and adhesives. The Company has a presence domestically and internationally, participating regularly in trade fairs and exhibitions. The Company exports mainly to South East Asia, the Middle East, and North Africa. The Company also supplies generic pharmaceutical formulation as 'Make to order' for bulk supply to hospitals and related healthcare organisations. The company has one reportable segment of Specialty Chemicals.
85GF Score

Get the complete analysis for BOM:543828

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹39.67
Price
₹39.04
GF Value